Literature DB >> 12758128

The human SPANX multigene family: genomic organization, alignment and expression in male germ cells and tumor cell lines.

Albert J W Zendman1, Jürgen Zschocke, Annemieke A van Kraats, Nicole J W de Wit, Maciej Kurpisz, Ulrich H Weidle, Dirk J Ruiter, Elisabeth H Weiss, Goos N P van Muijen.   

Abstract

Multigenicity is one of the features of cancer/testis-associated genes. In the present study we analyzed the number and expression of genes of the SPANX(CTp11) family of cancer/testis-associated genes. Genomic database analysis, next to the four previously described SPANX genes, revealed the presence of a novel gene: SPANXE. Moreover, we detected an allelic variant of SPANXB resulting in one amino acid substitution in the encoded protein: SPANXB'. Most SPANX genes are present on contig NT_011574 located at Xq26.3-Xq27.1. Based on expressed sequence tag databases and RT-PCR analysis three additional novel SPANX sequences were identified, though not represented so far in the human genome sequence. Sequence alignments justify a subdivision of this gene family based on the absence (SPANXA-likes) or presence (SPANXB) of an 18 base pair sequence stretch in the open reading frame. The alignments also reveal an unusually high level (99%) of intron homology. Furthermore, the nucleotide variations in the open reading frame almost all lead to amino acid substitutions. Southern blot and database analyses indicate that SPANX sequences are exclusively present in primates. With RT-PCR analysis on human sperm cell precursors and tumor cell lines most family members could be detected. SPANXB was only found in sperm cell precursors and could not be detected in the tumor cell lines tested. Overall SPANXA was the most frequently expressed SPANX variant in melanoma and glioblastoma cell lines.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12758128     DOI: 10.1016/s0378-1119(03)00497-9

Source DB:  PubMed          Journal:  Gene        ISSN: 0378-1119            Impact factor:   3.688


  24 in total

1.  Inverted repeat structure of the human genome: the X-chromosome contains a preponderance of large, highly homologous inverted repeats that contain testes genes.

Authors:  Peter E Warburton; Joti Giordano; Fanny Cheung; Yefgeniy Gelfand; Gary Benson
Journal:  Genome Res       Date:  2004-10       Impact factor: 9.043

2.  Expression of SpanX mRNA in testicular germ cell tumors.

Authors:  Michele Salemi; Aldo E Calogero; Paolo Bosco; Roberto Castiglione; Sandro La Vignera; Eugenia Borgione; Giancarlo Rappazzo; Enzo Vicari
Journal:  Hum Cell       Date:  2006-08       Impact factor: 4.174

3.  SPANX-B and SPANX-C (Xq27 region) gene dosage analysis in Down's syndrome subjects with undescended testes.

Authors:  Michele Salemi; Corrado Romano; Concetta Barone; Francesco Calí; Filippo Caraci; Carmelo Romano; Cataldo Scavuzzo; Francesco Scillato; Maria Grazia Salluzzo; Maria Piccione; Manuela Martines; Giovanni Corsello; Ferdinando Nicoletti; Paolo Bosco
Journal:  J Genet       Date:  2009-04       Impact factor: 1.166

4.  Exclusion of the 750-kb genetically unstable region at Xq27 as a candidate locus for prostate malignancy in HPCX1-linked families.

Authors:  Natalay Kouprina; Nicholas C O Lee; Adam Pavlicek; Alexander Samoshkin; Jung-Hyun Kim; Hee-Sheung Lee; Sudhir Varma; William C Reinhold; John Otstot; Greg Solomon; Sean Davis; Paul S Meltzer; Johanna Schleutker; Vladimir Larionov
Journal:  Genes Chromosomes Cancer       Date:  2012-06-26       Impact factor: 5.006

5.  Dynamic structure of the SPANX gene cluster mapped to the prostate cancer susceptibility locus HPCX at Xq27.

Authors:  Natalay Kouprina; Adam Pavlicek; Vladimir N Noskov; Greg Solomon; John Otstot; William Isaacs; John D Carpten; Jeffrey M Trent; Joanna Schleutker; J Carl Barrett; Jerzy Jurka; Vladimir Larionov
Journal:  Genome Res       Date:  2005-11       Impact factor: 9.043

6.  A major locus for hereditary prostate cancer in Finland: localization by linkage disequilibrium of a haplotype in the HPCX region.

Authors:  Agnes B Baffoe-Bonnie; Jeffrey R Smith; Dietrich A Stephan; Johanna Schleutker; John D Carpten; Tommi Kainu; Elizabeth M Gillanders; Mika Matikainen; Tanya M Teslovich; Teuvo Tammela; Raman Sood; Andrew M Balshem; Sheehan D Scarborough; Jianfeng Xu; William B Isaacs; Jeffrey M Trent; Olli-P Kallioniemi; Joan E Bailey-Wilson
Journal:  Hum Genet       Date:  2005-05-20       Impact factor: 4.132

7.  SPANX Control of Lamin A/C Modulates Nuclear Architecture and Promotes Melanoma Growth.

Authors:  Bertrand Fabre; Yongmei Feng; Ikrame Lazar; Ali Khateb; Patrick Turko; Julia M Martinez Gomez; Dennie T Frederick; Mitchell P Levesque; Lea Feld; Gao Zhang; Tongwu Zhang; Brian James; Jeny Shklover; Emily Avitan-Hersh; Ido Livneh; Marzia Scortegagna; Kevin Brown; Ola Larsson; Ivan Topisirovic; Haguy Wolfenson; Meenhard Herlyn; Keith Flaherty; Reinhard Dummer; Ze'ev A Ronai
Journal:  Mol Cancer Res       Date:  2020-06-22       Impact factor: 5.852

8.  The SPANX gene family of cancer/testis-specific antigens: rapid evolution and amplification in African great apes and hominids.

Authors:  Natalay Kouprina; Michael Mullokandov; Igor B Rogozin; N Keith Collins; Greg Solomon; John Otstot; John I Risinger; Eugene V Koonin; J Carl Barrett; Vladimir Larionov
Journal:  Proc Natl Acad Sci U S A       Date:  2004-02-18       Impact factor: 11.205

9.  Ras-association domain family 1C protein promotes breast cancer cell migration and attenuates apoptosis.

Authors:  Mark E Reeves; Scott W Baldwin; Melissa L Baldwin; Shin-Tai Chen; Jeremy M Moretz; Robert J Aragon; Xinmin Li; Donna D Strong; Subburaman Mohan; Yousef G Amaar
Journal:  BMC Cancer       Date:  2010-10-18       Impact factor: 4.430

10.  Sperm-derived SPANX-B is a clinically relevant tumor antigen that is expressed in human tumors and readily recognized by human CD4+ and CD8+ T cells.

Authors:  Giovanni Almanzar; Purevdorj B Olkhanud; Monica Bodogai; Chiara Dell'agnola; Dolgor Baatar; Stephen M Hewitt; Claudio Ghimenton; Mohan K Tummala; Ashani T Weeraratna; Keith Sean Hoek; Natalay Kouprina; Vladimir Larionov; Arya Biragyn
Journal:  Clin Cancer Res       Date:  2009-03-10       Impact factor: 12.531

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.